Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery

BJU Int. 2010 Jul;106(2):199-205. doi: 10.1111/j.1464-410X.2009.09118.x. Epub 2009 Dec 9.

Abstract

Objective: To evaluate extended lymph node dissection (LND) as a nodal staging tool in the treatment of invasive carcinoma of the urinary bladder and to suggest a reasonable proximal limit of the dissection.

Patients and methods: In all, 170 patients underwent radical cystectomy with extended LND up to the level of the inferior mesenteric artery. Specimens were evaluated as 13 separate packages from pre-designated anatomical locations. The number of LNs and presence of positive LNs (LN+) at each location was prospectively registered.

Results: The median (range) number of LNs removed was 24 (6-62). In all, 25.3% of the patients had LN+. The median (range) number of LN+ was 2 (1-20). Advanced T-stage was correlated with a higher risk of LN+ but not to the specific location of the LN+. Two patients had LN+ above the common iliac bifurcation with no LN+ more distally located within the pelvic region. All other patients with LN+ above the common iliac bifurcation had more distally located LN+. There were no skip lesions to LNs above the aortic bifurcation.

Conclusions: Extended LND above the common iliac bifurcation including the presacral area provides a more accurate LN staging compared with a standard pelvic LND. Extending the limits above the aortic bifurcation is not necessary from a staging perspective.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cystectomy / methods*
  • Epidemiologic Methods
  • Female
  • Humans
  • Lymph Node Excision / methods*
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Male
  • Mesenteric Artery, Inferior*
  • Middle Aged
  • Neoplasm Staging
  • Urinary Bladder Neoplasms / pathology*
  • Urinary Bladder Neoplasms / surgery